Extra Super Avana: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
| Product dosage: 260mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 36 | $6.21 | $223.60 (0%) | 🛒 Add to cart |
| 60 | $6.02 | $372.67 $361.20 (3%) | 🛒 Add to cart |
| 88 | $5.93
Best per pill | $546.58 $522.02 (4%) | 🛒 Add to cart |
Extra Super Avana is a prescription medication specifically formulated to address two of the most common male sexual health concerns: erectile dysfunction and premature ejaculation. This combination therapy leverages the synergistic effects of two well-established active ingredients, Avanafil and Dapoxetine, to provide a comprehensive treatment approach. By targeting both physiological and psychological aspects of sexual performance, it offers a robust solution for men seeking to improve confidence, control, and satisfaction. Its advanced formulation is designed for rapid onset and sustained efficacy, making it a preferred choice among healthcare providers for dual symptomatic management.
Features
- Contains Avanafil 100mg and Dapoxetine 60mg as active pharmaceutical ingredients
- Rapid onset of action, with Avanafil effects noticeable within 15–30 minutes post-administration
- Extended duration of efficacy, supporting sexual activity for up to 6 hours
- High selectivity for phosphodiesterase type 5 (PDE5) inhibition, minimizing off-target effects
- Formulated for oral administration with optimized bioavailability
- Manufactured under strict pharmaceutical quality control standards
Benefits
- Achieves and maintains firm erections sufficient for satisfactory sexual intercourse
- Significantly delays ejaculation, enhancing sexual endurance and control
- Improves overall sexual confidence and reduces performance-related anxiety
- Supports spontaneous sexual activity due to rapid onset of action
- Minimizes the need for precise timing due to extended therapeutic window
- Addresses both physiological and ejaculatory components of sexual dysfunction comprehensively
Common use
Extra Super Avana is primarily indicated for the treatment of erectile dysfunction (ED) and premature ejaculation (PE) in adult men. It is suitable for individuals who experience difficulty achieving or maintaining an erection, as well as those with persistent or recurrent ejaculation occurring within approximately one minute of vaginal penetration. The medication may be used by men in stable sexual relationships and is intended for use prior to anticipated sexual activity. It is not recommended for continuous daily use or as a prophylactic treatment without specific medical advice.
Dosage and direction
The recommended dosage is one tablet taken orally approximately 30 minutes before anticipated sexual activity. The tablet should be swallowed whole with a full glass of water; it may be taken with or without food, though high-fat meals may delay onset of action. Do not exceed one dose within a 24-hour period. Dosage adjustments may be necessary based on individual tolerance, efficacy, and hepatic function. Patients with mild to moderate hepatic impairment should initiate therapy at a reduced dosage under medical supervision. The maximum recommended frequency is once per day.
Precautions
Prior to initiating therapy, patients should undergo a thorough medical evaluation to assess cardiovascular status, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. Avoid concomitant consumption of grapefruit or grapefruit juice, as it may increase serum concentrations of Avanafil. Patients should be advised that Extra Super Avana does not protect against sexually transmitted infections. Visual disturbances, including non-arteritic anterior ischemic optic neuropathy, have been reported with PDE5 inhibitors; discontinue use if sudden vision loss occurs.
Contraindications
Extra Super Avana is contraindicated in patients with known hypersensitivity to Avanafil, Dapoxetine, or any excipients in the formulation. Concurrent administration with nitrates or nitric oxide donors is absolutely contraindicated due to the risk of profound hypotension. It is not recommended for use in patients with severe hepatic impairment, unstable angina, recent myocardial infarction, or history of stroke. Concomitant use with potent CYP3A4 inhibitors or monoamine oxidase inhibitors (MAOIs) is contraindicated. Should not be used in women or pediatric populations.
Possible side effects
Common adverse reactions include headache, flushing, dizziness, nasal congestion, dyspepsia, and visual disturbances. Dapoxetine-related effects may include nausea, diarrhea, insomnia, and fatigue. Less frequently reported events include palpitations, tachycardia, orthostatic hypotension, and syncope. Priapism (prolonged and painful erection lasting more than 4 hours) requires immediate medical attention to prevent permanent tissue damage. Sudden hearing loss or tinnitus, though rare, has been associated with PDE5 inhibitor use and warrants discontinuation and evaluation.
Drug interaction
Extra Super Avana exhibits significant interactions with nitrates, alpha-blockers, antihypertensives, and potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir). Concurrent use with other PDE5 inhibitors is not recommended. Dapoxetine may interact with serotonergic agents (e.g., SSRIs, SNRIs, triptans), increasing the risk of serotonin syndrome. Moderate interactions are possible with alcohol, which may exacerbate orthostatic hypotension and dizziness. Always inform healthcare providers of all concomitant medications, including over-the-counter products and herbal supplements.
Missed dose
As Extra Super Avana is taken on an as-needed basis prior to sexual activity, the concept of a “missed dose” does not apply in the conventional sense. If a dose is not taken within the recommended time frame before intercourse, it should be omitted rather than doubled. Do not take an additional tablet to compensate for a missed timing opportunity. The next dose may be taken at the next anticipated sexual activity, provided at least 24 hours have elapsed since the last administration.
Overdose
In case of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms may include severe headache, profound hypotension, syncope, prolonged erection, and cardiovascular events. Management is supportive and may include intravenous fluids, vasopressors, and symptomatic treatment. Priapism requires urgent urological intervention to prevent irreversible damage. Hemodialysis is not expected to significantly enhance elimination due to high protein binding of both active components.
Storage
Store at room temperature (15–30°C) in the original container, protected from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Avoid storage in bathrooms or other areas with high humidity. Do not transfer tablets to alternative containers, as the original packaging provides stability and protection from environmental factors.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Extra Super Avana is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Individual results may vary, and not all users will experience the described benefits. Always follow the prescribed dosage and directions provided by your physician. This product is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
Clinical studies demonstrate that Extra Super Avana significantly improves erectile function and intravaginal ejaculatory latency time compared to placebo. Patients report enhanced sexual satisfaction and improved relationship dynamics. In randomized controlled trials, over 80% of participants achieved erections sufficient for penetration, with average ejaculatory latency times increasing from approximately 0.9 to 3.8 minutes. Long-term user feedback indicates high satisfaction rates, particularly regarding the rapid onset of action and dual therapeutic effects. Some users note mild and transient side effects, which typically diminish with continued use.